Quantum Genomics Société Anonyme Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Quantum Genomics Société Anonyme Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for Quantum Genomics Société Anonyme, with the average target coming in at 0.10€. If it were to be achieved, this would result in a potential downside of approximately -16.67 percent from the most recent closing price in May, 2024. The high end is 0.10€, and the low is 0.10€. If you want to invest in ALQGC stock, you might also want to take a look at how its competitors are doing.
-16.67% Downside
Quantum Genomics Société Anonyme Fair Value Forecast for 2023 - 2025 - 2030
Quantum Genomics Société Anonyme's Price has seen impressive growth In the last four years, rising from 0.00€ to 0.00€ – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach 0.13€ – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VIRP Stock Forecast | Virbac | Outperform |
18
|
348.00€ | Buy/Sell | 348.34€ | 6.03% |
| ABVX Stock Forecast | ABIVAX Société Anonyme | Buy |
6
|
13.82€ | Buy/Sell | 24.80€ | 171.35% |
| VLA Stock Forecast | Valneva | Outperform |
12
|
3.38€ | Buy/Sell | 9.32€ | 170.71% |
| NANO Stock Forecast | Nanobiotix | Buy |
6
|
5.56€ | Buy/Sell | 11.13€ | 96.94% |
| IVA Stock Forecast | Inventiva | Buy |
11
|
2.99€ | Buy/Sell | 17.52€ | 351.51% |
Quantum Genomics Société Anonyme Revenue Forecast for 2023 - 2025 - 2030
Quantum Genomics Société Anonyme's Revenue has seen impressive growth In the last two years, rising from 1.20€M to 2.52€M – a growth of 110.00%. In the following year, 1 experts forecast Quantum Genomics Société Anonyme's Revenue will decrease by 100.00%, to 0.00€. In 2030, professionals predict that Quantum Genomics Société Anonyme's Revenue will decrease by 100.00%, to 0.00€.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IPH Stock Forecast | Innate Pharma | Outperform |
10
|
2.19€ | Buy/Sell | 6.32€ | 219.63% |
| ALCLS Stock Forecast | Cellectis | - |
10
|
2.60€ | Buy/Sell | 10.60€ | -100.00% |
| GNFT Stock Forecast | Genfit | Buy |
10
|
3.24€ | Buy/Sell | 9.26€ | 177.78% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALERS Stock Forecast | Eurobio Scientific Société a... | Buy |
16
|
14.50€ | Buy/Sell | 27.00€ | 106.90% |
| ADOC Stock Forecast | Adocia | Hold |
7
|
8.41€ | Buy/Sell | 9.70€ | 15.34% |
| DBV Stock Forecast | DBV Technologies | Outperform |
5
|
1.22€ | Buy/Sell | 4.07€ | 227.87% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TNG Stock Forecast | Transgene | Buy |
11
|
1.22€ | Buy/Sell | 3.50€ | 186.89% |
| OSE Stock Forecast | OSE Immunotherapeutics | Buy |
7
|
6.24€ | Buy/Sell | 7.15€ | 14.58% |
| ALONC Stock Forecast | Oncodesign Société Anonyme | - |
12
|
14.42€ | Buy/Sell | 17.43€ | -100.00% |
Quantum Genomics Société Anonyme EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Quantum Genomics Société Anonyme's EBITDA has seen an increase, rising from -13.85€M to -29.82€M. This represents a growth of 115.31%. According to 1 analysts, Quantum Genomics Société Anonyme's EBITDA will fall by 91.62% in the next year, reaching -2.50€M. Over the next seven years, experts predict that Quantum Genomics Société Anonyme's EBITDA will grow at a rate of 314.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ENXTPA:GKTX Stock Forecast | Genkyotex | - |
-15
|
3.20€ | Buy/Sell | 5.40€ | -100.00% |
| ABNX Stock Forecast | ABIONYX Pharma | Buy |
4
|
1.07€ | Buy/Sell | 10.50€ | 881.31% |
| SIGHT Stock Forecast | GenSight Biologics | Underperform |
9
|
0.40€ | Buy/Sell | 1.45€ | 0.00% |
Quantum Genomics Société Anonyme EBIT Forecast for 2023 - 2025 - 2030
Quantum Genomics Société Anonyme's EBIT has seen growth In the last two years, going from -13.86€M to -30.08€M – a gain of 117.03% In the following year, 1 experts forecast that Quantum Genomics Société Anonyme's EBIT will decrease by 90.36%, to -2.90€M. For the next seven years, the forecast is forEBIT to grow by 208.12%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALVIO Stock Forecast | Valerio Therapeutics Société... | - |
8
|
0.13€ | Buy/Sell | 1.30€ | 15.38% |
| POXEL Stock Forecast | Poxel | - |
9
|
0.60€ | Buy/Sell | 3.50€ | -100.00% |
| PHXM Stock Forecast | PHAXIAM Therapeutics | Buy |
4
|
2.92€ | Buy/Sell | 9.85€ | 134.59% |
Quantum Genomics Société Anonyme EPS Price Prediction Forecast for 2023 - 2025 - 2030
Quantum Genomics Société Anonyme's EPS has seen impressive growth In the last four years, rising from -0.44€ to 0.00€ – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.38€ – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LYS Stock Forecast | Lysogene | - |
0
|
1.70€ | Buy/Sell | 0.00€ | -100.00% |
| ALHYG Stock Forecast | Hybrigenics | - |
0
|
0.01€ | Buy/Sell | 0.00€ | -100.00% |
| ALBPS Stock Forecast | Biophytis | - |
0
|
0.00€ | Buy/Sell | 10.00€ | 0.00% |
Site Navigation
.jpg)